France· FR:61631770
FLUDEX 1,5 mg, comprimé pelliculé à libération prolongée
A indapamide product containing indapamide hémihydraté, registered in France by LES LABORATOIRES SERVIER, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Indapamide is registered in 16 of 19 countries.
Countries holding a registration under ATC C03BA11 (indapamide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Indapamide · ATC C03BA11
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of indapamide costs, country by country.
Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.16 in Spain to $0.58 in Switzerland — a ×3.7 gap.
- France: $0.26 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Indapamide · price per daily dose (2.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- FR France$0.26
- IT Italy$0.17
- ES Spain$0.16
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- INDAPAMIDE HÉMIHYDRATÉ
- Manufacturer
- LES LABORATOIRES SERVIER
- Country
- France (FR)
- ATC code
- C03BA11
- ATC class
- Indapamide
- Defined daily dose
- 2.5 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
2 priced- cip133400933827465plaquette(s) PVC-Aluminium de 30 comprimé(s)EUR 4.14
- cip133400935781420plaquette(s) PVC-Aluminium de 90 comprimé(s)EUR 11.53
- cip133400933827694plaquette(s) PVC-Aluminium de 100 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
347 interactions on record for indapamide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Indapamide · interactions on record
347 records
- 4 severe
- 208 moderate
- 18 minor
- 69 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
48 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Indapamide in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Germany · Indapamid Ct, Indapamid Puren
- United Kingdom (Northern Ireland) · Indapamide Hemihydate Generics Uk, Indapamide Hemihydrate
- Italy · Millibar, Pressural
- Lithuania · Indatens
- Latvia · Indatens
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/88d16cf7-5d50-4540-a298-365af29f3fb5 GET /v1/drugs/88d16cf7-5d50-4540-a298-365af29f3fb5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61631770",
"date_amm": "1994-12-08",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "INDAPAMIDE HÉMIHYDRATÉ",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about indapamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.